Andy Gillespie
Impact in
Papers in
-
- Neurofibromatosis and Schwannoma Cases 5
- Neuroblastoma Research and Treatments 4
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Frank M. Balis (7 shared papers)Gregory H. Reaman (3 shared papers)Roger J. Packer (2 shared papers)Richard L. Heideman (2 shared papers)Diane E. Cole (2 shared papers)Peter C. Adamson (4 shared papers)Stacey L. Berg (3 shared papers)Brigitte C. Widemann (6 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Cancers (1 paper)Frontiers in Oncology (1 paper)Journal of the International Neuropsychological Society (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesUkraine
In The Last Decade
Andy Gillespie
13 papers receiving 461 citations
Peers
Comparison fields: 5 of 56
- Neurology 214
- Genetics 143
- Pulmonary and Respiratory Medicine 213
- Oncology 149
- Hematology 33
Countries citing papers authored by Andy Gillespie
This map shows the geographic impact of Andy Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Gillespie more than expected).
Fields of papers citing papers by Andy Gillespie
This network shows the impact of papers produced by Andy Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Gillespie. The network helps show where Andy Gillespie may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy Gillespie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. | 1989 | 111 |
| 2 | 2014 | 90 | |
| 3 | 2002 | 74 | |
| 4 | Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. | 1998 | 51 |
| 5 | 1992 | 46 | |
| 6 | Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. | 1992 | 27 |
| 7 | 2004 | 25 | |
| 8 | Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule. | 1990 | 18 |
| 9 | 2020 | 14 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 1 | |
| 13 | 2024 | 1 |
About Andy Gillespie
Andy Gillespie is a scholar working on Neurology, Molecular Biology, Pediatrics, Perinatology and Child Health, Oncology and Epidemiology, having authored 13 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers), Neuroblastoma Research and Treatments (4 papers), Meningioma and schwannoma management (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Pharmaceutical studies and practices (2 papers), Statistical Methods in Clinical Trials (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Neurology (214 citations), Genetics (143 citations), Pulmonary and Respiratory Medicine (213 citations), Oncology (149 citations) and Hematology (33 citations). Andy Gillespie has collaborated with scholars based in United States and Ukraine. Frequent co-authors include Frank M. Balis, Gregory H. Reaman, Roger J. Packer, Richard L. Heideman, Diane E. Cole, Peter C. Adamson, Stacey L. Berg, Brigitte C. Widemann, Susan M. Blaney and David G. Poplack. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Frontiers in Oncology, Journal of the International Neuropsychological Society and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.